Toward the Design and Validation of a Scale to Assess Amotivational Syndrome in Chronic Marijuana Users (ESATHC)

  • Guillermo A. CastañoEmail author
  • Elisardo Becoña
  • Sandra Milena Restrepo
  • Orlando Scoppetta
Brief Report

There is a sufficient amount of evidence of the short- and medium-term adverse effects on mental health from continued use of marijuana, such as dependence, psychotic outbreaks after intense consumption, schizophrenia in predisposed people, and alterations in working memory and concentration (Hall 2015; Volkow et al. 2014). In addition, the occurrence of an amotivational syndrome (AS) has been referenced (WHO 1997) or suggested (American Psychiatric Association 2013). Some argue for its existence (e.g., Bonnett et al. 2015; Lac and Luk 2018), whereas others deny or question the concept (e.g., Barnwell et al. 2006) due to the studies’ limitations—which include using small sample sizes, incorporating polydrugs, not ruling out a comorbid illness that could produce amotivation (e.g., depression, apathy, mental disorders, executive dysfunction), the type of consumer in terms of frequency and amount of consumption (i.e., heavy or light), not taking into account the age of onset or type of...


Funding Information

This work was supported by the CES University, Colombia; Funlam University, Colombia; and the University of Santiago de Compostela, Spain.

Compliance with Ethical Standards

This investigation was authorized by the Ethics Committee of the CES University. All participants signed the informed consent to take part in the study.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.CrossRefGoogle Scholar
  2. Atienza, F. L., Pons, D., Balaguer, I., & García-Merita, M. (2000). Propiedades psicométricas de la Escala de Satisfacción con la Vida en adolescentes. Psicothema, 12, 314–319.Google Scholar
  3. Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (2001). The alcohol use disorders identification test: guidelines for use in primary care (2nd ed.). Geneva: World Health Organization.Google Scholar
  4. Barnwell, S. S., Earleywine, M., & Wilcox, R. (2006). Cannabis, motivation, and life satisfaction in an internet sample. Substance Abuse Treatment Prevention and Policy, 1, 1–9.CrossRefGoogle Scholar
  5. Beck, A. T., Steer, R. A., & Brown, G. K. (2011). Manual. BDI-II. Inventario de Depresión de Beck-II. Madrid: Pearson.Google Scholar
  6. Bonnett, L., Borda, T., Scherbaum, N., & Specka, M. (2015). Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (part II): psychiatric complaints and their relation to delta-9-tetrahydrocannabinal and its metabolites in serum. Drug and Alcohol Dependence, 155, 302–306.CrossRefGoogle Scholar
  7. Caeiro, L., Silva, T., Ferro, J. M., Pais-Ribeiro, J., & Figueira, M. L. (2012). Propiedades métricas da versão portuguesa da escala de avaliação de Apatia. Revista de Psicologia, Saúde & Doenças, 13, 266–282.Google Scholar
  8. Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The satisfaction with life scale. Journal of Personality Assessment, 49, 71–75.CrossRefGoogle Scholar
  9. Gold, M. S. (1989). Marijuana. New York, NY: Springer.CrossRefGoogle Scholar
  10. Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction, 110, 19–35.CrossRefGoogle Scholar
  11. Lac, A., & Luk, J. W. (2018). Testing the amotivational syndrome: marihuana use longitudinally predicts lower self-efficacy even after controlling for demographics, personality, and alcohol and cigarette use. Prevention Science, 19, 17–126.CrossRefGoogle Scholar
  12. Levy, R., & Czernecki, V. (2006). Apathy and the basal ganglia [supplemental material]. Journal of Neuroloy, 253 (Suppl. 7), 54–61.Google Scholar
  13. Marin, R. S., Biedrzycki, R. C., & Firinciogullari, S. (1991). Reliability and validity of the apathy evaluation scale. Psychiatry Research, 38, 143–162.CrossRefGoogle Scholar
  14. Ospina-Díaz, J. M., Manrique-Abril, F. G., & Ariza, N. E. (2012). Reliability and dimensionality of the Alcohol Use Disorders Identification Test (AUDIT) in university students from Tunja (Colombia). Salud Uninorte, 28, 276–282.Google Scholar
  15. Ruiz-Sánchez de León, J. M., Pedrero-Pérez, E. J., Lozoya-Delgado, P., Llanero-Luque, M., Rojo-Mota, G., & Puerta-García, C. (2012). Prefrontal Symptoms Inventory for clinical evaluation of addictions in everyday life: development process and psychometric properties. Revista de Neurologia, 54, 649–663.CrossRefGoogle Scholar
  16. Sano, K., Mishima, K., Koushi, E., Orito, K., Egashira, N., Irie, K., & Fujiwara, M. (2008). Δ9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience, 151, 320–328.CrossRefGoogle Scholar
  17. Sanz, J., & García-Vera, M. P. (2009). The Beck Depression Inventory-second edition (BDI-II). School and Health, 21, 331–342.Google Scholar
  18. Schumacker, R., & Lomax, R. A. (2004). Beginner’s guide to structural equation modeling (2nd ed.). New York, NY: Erlbaum.CrossRefGoogle Scholar
  19. Tabachnick, B. G., & Fidell, L. S. (2013). Using multivariate statistics (6th ed.). New York, NY: Pearson.Google Scholar
  20. Tziraki, S. (2012). Mental disorders and neuropsychological impairment related to chronic use of cannabis. Revista de Neurologia, 54, 750–760.CrossRefGoogle Scholar
  21. Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370, 2219–2227.CrossRefGoogle Scholar
  22. Volkow, N. D., Swanson, J. M., Evins, E., DeLisi, L. E., Meier, M. H., Gonzalez, R., & Baler, R. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry, 73, 291–297.Google Scholar
  23. World Health Organization. (1997). Cannabis: a health perspective and research agenda. Geneva: Author.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Faculty of MedicineCES UniversityMedellínColombia
  2. 2.Faculty of PsychologyUniversity of Santiago de CompostelaSantiago de CompostelaSpain
  3. 3.University Luis AmigoMedellínColombia
  4. 4.Ministry of Health, Republic of ColombiaBogotáColombia

Personalised recommendations